Chemed Co. (NYSE:CHE) Shares Sold by LVW Advisors LLC

LVW Advisors LLC trimmed its position in shares of Chemed Co. (NYSE:CHEFree Report) by 2.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 861 shares of the company’s stock after selling 25 shares during the quarter. LVW Advisors LLC’s holdings in Chemed were worth $553,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Rise Advisors LLC acquired a new position in shares of Chemed during the first quarter worth about $26,000. GAMMA Investing LLC acquired a new position in shares of Chemed during the fourth quarter worth about $37,000. Principal Securities Inc. acquired a new position in shares of Chemed during the fourth quarter worth about $51,000. SRS Capital Advisors Inc. increased its stake in shares of Chemed by 110.6% during the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock worth $58,000 after acquiring an additional 52 shares during the period. Finally, Mather Group LLC. acquired a new position in Chemed during the first quarter worth about $67,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Patrick P. Grace sold 284 shares of the stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the sale, the director now directly owns 3,270 shares in the company, valued at $1,769,004.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Kevin J. Mcnamara sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the sale, the chief executive officer now owns 108,549 shares in the company, valued at $61,605,899.46. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $540.98, for a total transaction of $153,638.32. Following the sale, the director now owns 3,270 shares in the company, valued at approximately $1,769,004.60. The disclosure for this sale can be found here. Insiders have sold 5,784 shares of company stock worth $3,240,053 over the last ninety days. 3.32% of the stock is currently owned by insiders.

Analysts Set New Price Targets

CHE has been the topic of several recent analyst reports. Royal Bank of Canada lowered their target price on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 21st. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th.

Get Our Latest Report on Chemed

Chemed Trading Down 0.6 %

Shares of CHE opened at $539.54 on Tuesday. The firm’s 50-day moving average is $556.04 and its two-hundred day moving average is $588.78. Chemed Co. has a twelve month low of $492.84 and a twelve month high of $654.62. The firm has a market capitalization of $8.17 billion, a P/E ratio of 29.04, a PEG ratio of 2.23 and a beta of 0.43.

Chemed (NYSE:CHEGet Free Report) last released its quarterly earnings results on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing the consensus estimate of $5.09 by ($0.41). The business had revenue of $589.23 million during the quarter, compared to analyst estimates of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. Analysts predict that Chemed Co. will post 21.54 EPS for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Stockholders of record on Thursday, May 30th were given a $0.40 dividend. The ex-dividend date was Thursday, May 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.30%. Chemed’s dividend payout ratio is presently 8.61%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.